News Release
Consumer Advocacy Group Attacks FDA for Slow Approval of Cancer Treatment
May 14, 1992—(Washington, DC) The Competitive Enterprise Institute today charged that FDA’s delay in approving Interleukin-2 may have cost as many as 3500 lives. IL-2…
News Release
AIDS Protest at FDA: The Issue Is Freedom
The Competitive Enterprise Institute, a Washington-based free market advocacy group, today expressed its support for the AIDS protest at the Food & Drug Administration…